Irish Pain Society backs use of medical cannabis
A group representing medical specialists who treat patients with chronic pain disorders disagrees with the view of the Health Product Regulatory Authority, following its recommendation against the use of medical cannabis for the treatment of chronic pain.
The Irish Pain Society’s stance comes in the wake of the publication of a HPRA report in which it recommended that if the Government approves access to cannabis-based treatments on compassionate grounds, this access should be limited to some patients with MS; some who may suffer nausea associated with chemotherapy; and others with specific forms of epilepsy.
